despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..
share this comment:
.
cambridge's bluebird bio licenses delivery tech to novartis, gsk.. the study used data of 1,082 ct scans of stroke patients across 70 hospitals in britain..